Health Care Sector

Top Holdings

334 Securities

Top Sector

Health Care

Min. Investment

$14,000

Expense Ratio

0.00%

Dividend Yield

1.36%

Description

This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.

Period From - To

Simulated Investment

Slippage (bps)

Rebalance Frequency

Generated using historical backtest simulation

Our interactive backtest tools is not reflective of actual live performance and these returns are hypothetical. Actual costs resulting from live trading may differ significantly, and backtest pricing data is not indicative realtime pricing data. Past performance is not an indicator of future performance. Learn more about how backtests work on Double here

Starting Point Holdings

NameSymbolAllocation
Eli Lilly & Co.LLY
11.80%
UnitedHealth Group, Inc.UNH
8.53%
AbbVie, Inc.ABBV
4.81%
Johnson & JohnsonJNJ
4.77%
Merck & Co., Inc.MRK
3.66%
Thermo Fisher Scientific, Inc.TMO
3.64%
Abbott LaboratoriesABT
3.26%
Intuitive Surgical, Inc.ISRG
2.95%
Danaher Corp.DHR
2.90%
Amgen, Inc.AMGN
2.73%
Pfizer Inc.PFE
2.64%
Boston Scientific Corp.BSX
2.08%
Stryker Corp.SYK
2.03%
Vertex Pharmaceuticals, Inc.VRTX
2.01%
Medtronic PlcMDT
1.88%
Gilead Sciences, Inc.GILD
1.72%
Bristol Myers Squibb Co.BMY
1.71%
Regeneron Pharmaceuticals, Inc.REGN
1.70%
Elevance Health, Inc.ELV
1.59%
The Cigna GroupCI
1.47%
Zoetis, Inc.ZTS
1.39%
HCA Healthcare, Inc.HCA
1.31%
CVS Health Corp.CVS
1.19%
Becton, Dickinson & Co.BDX
1.12%
McKesson Corp.MCK
1.06%
Cencora, Inc.COR
0.69%
IQVIA Holdings, Inc.IQV
0.68%
Edwards Lifesciences Corp.EW
0.67%
Agilent Technologies, Inc.A
0.64%
GE Healthcare Technologies, Inc.GEHC
0.63%
IDEXX Laboratories, Inc.IDXX
0.59%
Alnylam Pharmaceuticals, Inc.ALNY
0.59%
ResMed, Inc.RMD
0.56%
Veeva Systems, Inc.VEEV
0.54%
Centene Corp.CNC
0.53%
Humana, Inc.HUM
0.52%
Mettler-Toledo International, Inc.MTD
0.47%
DexCom, Inc.DXCM
0.46%
Cardinal Health, Inc.CAH
0.44%
Biogen, Inc.BIIB
0.44%
Illumina, Inc.ILMN
0.37%
STERIS Plc (Ireland)STE
0.36%
Zimmer Biomet Holdings, Inc.ZBH
0.35%
The Cooper Cos., Inc.COO
0.34%
West Pharmaceutical Services, Inc.WST
0.34%
Waters Corp.WAT
0.33%
Hologic, Inc.HOLX
0.30%
Baxter International, Inc.BAX
0.30%
Labcorp Holdings, Inc.LH
0.29%
Moderna, Inc.MRNA
0.28%
Molina Healthcare, Inc.MOH
0.27%
Insulet Corp.PODD
0.27%
Quest Diagnostics, Inc.DGX
0.26%
Tenet Healthcare Corp.THC
0.25%
Align Technology, Inc.ALGN
0.25%
Avantor, Inc.AVTR
0.25%
United Therapeutics Corp.UTHR
0.25%
Revvity, Inc.RVTY
0.23%
Universal Health Services, Inc.UHS
0.22%
Natera, Inc.NTRA
0.22%
Viatris, Inc.VTRS
0.22%
BioMarin Pharmaceutical, Inc.BMRN
0.21%
EXACT Sciences Corp.EXAS
0.21%
Neurocrine Biosciences, Inc.NBIX
0.19%
Insmed, Inc.INSM
0.18%
Teleflex, Inc.TFX
0.18%
Bio-Techne Corp.TECH
0.18%
Catalent, Inc.CTLT
0.18%
Royalty Pharma PlcRPRX
0.17%
Solventum Corp.SOLV
0.17%
Vaxcyte, Inc.PCVX
0.17%
Incyte Corp.INCY
0.17%
Charles River Laboratories International, Inc.CRL
0.16%
Encompass Health Corp.EHC
0.16%
Medpace Holdings, Inc.MEDP
0.15%
Henry Schein, Inc.HSIC
0.15%
Chemed Corp.CHE
0.14%
DaVita, Inc.DVA
0.14%
The Ensign Group, Inc.ENSG
0.14%
Sarepta Therapeutics, Inc.SRPT
0.13%
Lantheus Holdings, Inc.LNTH
0.13%
Repligen Corp.RGEN
0.12%
HealthEquity, Inc.HQY
0.12%
Penumbra, Inc.PEN
0.12%
Exelixis, Inc.EXEL
0.12%
Intra-Cellular Therapies, Inc.ITCI
0.12%
Jazz Pharmaceuticals PlcJAZZ
0.11%
Bio-Rad Laboratories, Inc.BIO
0.11%
Glaukos Corp.GKOS
0.11%
Halozyme Therapeutics, Inc.HALO
0.11%
Bruker Corp.BRKR
0.10%
Masimo Corp.MASI
0.10%
Viking Therapeutics, Inc.VKTX
0.10%
Elanco Animal Health, Inc.ELAN
0.10%
Globus Medical, Inc.GMED
0.10%
Inspire Medical Systems, Inc.INSP
0.10%
Cytokinetics, Inc.CYTK
0.09%
Revolution Medicines, Inc.RVMD
0.09%
Merit Medical Systems, Inc.MMSI
0.09%
Option Care Health, Inc.OPCH
0.09%
Dentsply Sirona, Inc.XRAY
0.08%
Ionis Pharmaceuticals, Inc.IONS
0.08%
Blueprint Medicines Corp.BPMC
0.08%
Acadia Healthcare Co., Inc.ACHC
0.08%
Doximity, Inc.DOCS
0.08%
Corcept Therapeutics, Inc.CORT
0.07%
Organon & Co.OGN
0.07%
Ultragenyx Pharmaceutical, Inc.RARE
0.07%
Alkermes PlcALKS
0.07%
Integer Holdings Corp.ITGR
0.07%
RadNet, Inc.RDNT
0.07%
ICU Medical, Inc.ICUI
0.07%
TransMedics Group, Inc.TMDX
0.06%
Crinetics Pharmaceuticals, Inc.CRNX
0.06%
CRISPR Therapeutics AGCRSP
0.06%
Haemonetics Corp.HAE
0.06%
Avidity Biosciences, Inc.RNA
0.06%
Select Medical Holdings Corp.SEM
0.06%
Biohaven Ltd.BHVN
0.06%
Prestige Consumer Healthcare, Inc.PBH
0.06%
Axonics, Inc.AXNX
0.06%
Krystal Biotech, Inc.KRYS
0.06%
Perrigo Co. PlcPRGO
0.06%
TG Therapeutics, Inc.TGTX
0.06%
Denali Therapeutics, Inc.DNLI
0.06%
ADMA Biologics, Inc.ADMA
0.05%
PROCEPT BioRobotics Corp.PRCT
0.05%
Hims & Hers Health, Inc.HIMS
0.05%
Envista Holdings Corp.NVST
0.05%
Amedisys, Inc.AMED
0.05%
Cerevel Therapeutics Holdings, Inc.C088658
0.05%
Arcellx, Inc.ACLX
0.05%
CorVel Corp.CRVL
0.05%
Neogen Corp.NEOG
0.05%
LivaNova PlcLIVN
0.05%
BridgeBio Pharma, Inc.BBIO
0.05%
Axsome Therapeutics, Inc.AXSM
0.05%
Astrana Health, Inc.ASTH
0.04%
Madrigal Pharmaceuticals, Inc.MDGL
0.04%
Amicus Therapeutics, Inc.FOLD
0.04%
Twist Bioscience Corp.TWST
0.04%
PTC Therapeutics, Inc.PTCT
0.04%
Guardant Health, Inc.GH
0.04%
Veracyte, Inc.VCYT
0.04%
R1 RCM, Inc.RCM
0.04%
Addus HomeCare Corp.ADUS
0.04%
Agios Pharmaceuticals, Inc.AGIO
0.04%
Evolent Health, Inc.EVH
0.04%
Rhythm Pharmaceuticals, Inc.RYTM
0.04%
Inari Medical, Inc.NARI
0.04%
Surgery Partners, Inc.SGRY
0.04%
Catalyst Pharmaceuticals, Inc.CPRX
0.04%
QuidelOrtho Corp.QDEL
0.04%
Tandem Diabetes Care, Inc.TNDM
0.04%
Arrowhead Pharmaceuticals, Inc.ARWR
0.04%
Enovis Corp.ENOV
0.04%
Apellis Pharmaceuticals, Inc.APLS
0.03%
Azenta, Inc.AZTA
0.03%
Premier, Inc.PINC
0.03%
Myriad Genetics, Inc.MYGN
0.03%
IDEAYA Biosciences, Inc.IDYA
0.03%
Protagonist Therapeutics, Inc.PTGX
0.03%
CONMED Corp.CNMD
0.03%
Amphastar Pharmaceuticals, Inc.AMPH
0.03%
Ligand Pharmaceuticals, Inc.LGND
0.03%
Iovance Biotherapeutics, Inc.IOVA
0.03%
Vericel Corp.VCEL
0.03%
iRhythm Technologies, Inc.IRTC
0.03%
Intellia Therapeutics, Inc.NTLA
0.03%
Supernus Pharmaceuticals, Inc.SUPN
0.03%
Omnicell, Inc.OMCL
0.03%
Dyne Therapeutics, Inc.DYN
0.03%
MannKind Corp.MNKD
0.03%
Geron Corp.GERN
0.03%
LeMaitre Vascular, Inc.LMAT
0.03%
Keros Therapeutics, Inc.KROS
0.03%
Springworks Therapeutics, Inc.SWTX
0.03%
Harrow, Inc.HROW
0.03%
NovoCure Ltd.NVCR
0.03%
National HealthCare Corp.NHC
0.03%
NeoGenomics, Inc.NEO
0.03%
Patterson Cos., Inc.PDCO
0.03%
Celldex Therapeutics, Inc.CLDX
0.03%
RxSight, Inc.RXST
0.03%
Fortrea Holdings, Inc.FTRE
0.03%
ACADIA Pharmaceuticals, Inc.ACAD
0.03%
Beam Therapeutics, Inc.BEAM
0.03%
Teladoc Health, Inc.TDOC
0.03%
Kymera Therapeutics, Inc.KYMR
0.02%
AMN Healthcare Services, Inc.AMN
0.02%
Immunovant, Inc.IMVT
0.02%
Akero Therapeutics, Inc.AKRO
0.02%
10X Genomics, Inc.TXG
0.02%
Syndax Pharmaceuticals, Inc.SNDX
0.02%
Progyny, Inc.PGNY
0.02%
BioCryst Pharmaceuticals, Inc.BCRX
0.02%
AtriCure, Inc.ATRC
0.02%
Dynavax Technologies Corp.DVAX
0.02%
Nurix Therapeutics, Inc.NRIX
0.02%
Scholar Rock Holding Corp.SRRK
0.02%
Cassava Sciences, Inc.SAVA
0.02%
Integra LifeSciences Holdings Corp.IART
0.02%
Tilray Brands, Inc.TLRY
0.02%
Edgewise Therapeutics, Inc.EWTX
0.02%
U.S. Physical Therapy, Inc.USPH
0.02%
Certara, Inc.CERT
0.02%
Novavax, Inc.NVAX
0.02%
Arvinas, Inc.ARVN
0.02%
Recursion Pharmaceuticals, Inc.RXRX
0.02%
Travere Therapeutics, Inc.TVTX
0.02%
Collegium Pharmaceutical, Inc.COLL
0.02%
STAAR Surgical Co.STAA
0.02%
CareDx, Inc.CDNA
0.02%
Xencor, Inc.XNCR
0.02%
Viridian Therapeutics, Inc.VRDN
0.02%
Brookdale Senior Living, Inc.BKD
0.02%
Rocket Pharmaceuticals, Inc.RCKT
0.02%
Ocular Therapeutix, Inc.OCUL
0.02%
Schrödinger, Inc.SDGR
0.02%
Innoviva, Inc.INVA
0.02%
Harmony Biosciences Holdings, Inc.HRMY
0.02%
Pediatrix Medical Group, Inc.MD
0.02%
Phreesia, Inc.PHR
0.02%
Amneal Pharmaceuticals, Inc.AMRX
0.02%
Avanos Medical, Inc.AVNS
0.02%
Kiniksa Pharmaceuticals International PlcKNSA
0.02%
Alignment Healthcare, Inc.ALHC
0.02%
Owens & Minor, Inc.OMI
0.02%
The Pennant Group, Inc.PNTG
0.02%
Artivion, Inc.AORT
0.02%
ANI Pharmaceuticals, Inc.ANIP
0.02%
Aurinia Pharmaceuticals, Inc.AUPH
0.02%
Tarsus Pharmaceuticals, Inc.TARS
0.02%
Praxis Precision Medicines, Inc.PRAX
0.02%
AdaptHealth Corp.AHCO
0.02%
Disc Medicine, Inc.IRON
0.01%
Arcutis Biotherapeutics, Inc.ARQT
0.01%
Agilon Health, Inc.AGL
0.01%
Day One Biopharmaceuticals, Inc.DAWN
0.01%
PetIQ, Inc.PETQ
0.01%
BioLife Solutions, Inc.BLFS
0.01%
Castle Biosciences, Inc.CSTL
0.01%
Arcus Biosciences, Inc.RCUS
0.01%
Spyre Therapeutics, Inc.SYRE
0.01%
Kura Oncology, Inc.KURA
0.01%
Pacira Biosciences, Inc.PCRX
0.01%
Establishment Labs Holdings, Inc.ESTA
0.01%
Evolus, Inc.EOLS
0.01%
Embecta Corp.EMBC
0.01%
Vir Biotechnology, Inc.VIR
0.01%
Cogent Biosciences, Inc.COGT
0.01%
Community Health Systems, Inc.CYH
0.01%
Pliant Therapeutics, Inc.PLRX
0.01%
HealthStream, Inc.HSTM
0.01%
Avid Bioservices, Inc.CDMO
0.01%
Zymeworks, Inc.ZYME
0.01%
Ironwood Pharmaceuticals, Inc.IRWD
0.01%
Phathom Pharmaceuticals, Inc.PHAT
0.01%
Prothena Corp. PlcPRTA
0.01%
Alphatec Holdings, Inc.ATEC
0.01%
Relay Therapeutics, Inc.RLAY
0.01%
Orthofix Medical, Inc.OFIX
0.01%
Surmodics, Inc.SRDX
0.01%
Simulations Plus, Inc.SLP
0.01%
Enliven Therapeutics, Inc.ELVN
0.01%
GoodRx Holdings, Inc.GDRX
0.01%
EyePoint Pharmaceuticals, Inc.EYPT
0.01%
Revance Therapeutics, Inc.RVNC
0.01%
OPKO Health, Inc.OPK
0.01%
Arcturus Therapeutics Holdings, Inc.ARCT
0.01%
Emergent BioSolutions, Inc.EBS
0.01%
Liquidia Corp.LQDA
0.01%
Sana Biotechnology, Inc.SANA
0.01%
Varex Imaging Corp.VREX
0.01%
Health Catalyst, Inc.HCAT
0.01%
Phibro Animal Health Corp.PAHC
0.01%
SI-BONE, Inc.SIBN
0.01%
ImmunityBio, Inc.IBRX
0.01%
Anavex Life Sciences Corp.AVXL
0.01%
Altimmune, Inc.ALT
0.01%
AnaptysBio, Inc.ANAB
0.01%
Adaptive Biotechnologies Corp.ADPT
0.01%
Quanterix Corp.QTRX
0.01%
REGENXBIO, Inc.RGNX
0.01%
Pacific Biosciences of California, Inc.PACB
0.01%
Standard BioTools, Inc.LAB
0.01%
OrthoPediatrics Corp.KIDS
0.01%
Y-mAbs Therapeutics, Inc.YMAB
0.01%
Cross Country Healthcare, Inc.CCRN
0.01%
GRAIL, Inc.GRAL
0.01%
Korro Bio, Inc.KRRO
0.01%
ZimVie, Inc.ZIMV
0.01%
Allogene Therapeutics, Inc.ALLO
0.01%
Fulgent Genetics, Inc.FLGT
0.01%
Stoke Therapeutics, Inc.STOK
0.01%
CryoPort, Inc.CYRX
0.01%
SAGE Therapeutics, Inc.SAGE
0.01%
Astria Therapeutics, Inc.ATXS
0.01%
OraSure Technologies, Inc.OSUR
0.01%
Theravance Biopharma, Inc.TBPH
0.01%
Cerus Corp.CERS
0.00%
Alector, Inc.ALEC
0.00%
Enhabit, Inc.EHAB
0.00%
uniQure NVQURE
0.00%
SIGA Technologies, Inc.SIGA
0.00%
DocGo, Inc.DCGO
0.00%
Vanda Pharmaceuticals, Inc.VNDA
0.00%
Editas Medicine, Inc.EDIT
0.00%
AngioDynamics, Inc.ANGO
0.00%
Fate Therapeutics, Inc.FATE
0.00%
Aldeyra Therapeutics, Inc.ALDX
0.00%
Enanta Pharmaceuticals, Inc.ENTA
0.00%
Dianthus Therapeutics, Inc.DNTH
0.00%
Accolade, Inc.ACCD
0.00%
Amylyx Pharmaceuticals, Inc.AMLX
0.00%
Treace Medical Concepts, Inc.TMCI
0.00%
4D Molecular Therapeutics, Inc.FDMT
0.00%
Inogen, Inc.INGN
0.00%
MeiraGTx Holdings PlcMGTX
0.00%
Organogenesis Holdings, Inc.ORGO
0.00%
iTeos Therapeutics, Inc.ITOS
0.00%
IGM Biosciences, Inc.IGMS
0.00%
ModivCare, Inc.MODV
0.00%
Nevro Corp.NVRO
0.00%
MacroGenics, Inc.MGNX
0.00%
Zentalis Pharmaceuticals, Inc.ZNTL
0.00%
Ventyx Biosciences, Inc.VTYX
0.00%
American Well Corp.AMWL
0.00%
Coherus BioSciences, Inc.CHRS
0.00%
Seer, Inc. (California)SEER
0.00%
Aclaris Therapeutics, Inc.ACRS
0.00%
Rapt Therapeutics, Inc.RAPT
0.00%
Repare Therapeutics, Inc.RPTX
0.00%
ALX Oncology Holdings, Inc.ALXO
0.00%

Design your own stock index

© Double Finance, 2024

Double is a registered investment adviser with the US Securities and Exchange Commission (SEC). While such registration does not imply a certain level of skill, it does require us to follow federal regulations that protect you, the investor. By law, we must provide investment advice that is in the best interest of our client. Please refer to Double's Form CRS for important additional information.

The publicly available portions of the Platform (i.e., the sections of the Platform that are available to individuals who are not party to a Client Agreement - including double.finance) are provided for educational purposes only and are not intended to provide legal, tax, or financial planning advice. To the extent that any of the content published on publicly available portions of the Platform may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Nothing on the publicly available portions of the Platform should be construed as a solicitation or offer, or recommendation, to buy or sell any security. All charts, figures, and graphs on the publicly available websites are for illustrative purposes only. Before investing, you should consider whether any investment, investment strategy, security, other asset, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You are also encouraged to consult your legal, tax, or investment professional regarding your specific situation. Registration does not imply a certain level of skill or training.

Investing involves risk. The value of your investment will fluctuate, and you may gain or lose money.

The contents of the Platform may contain forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates, and projections about the financial industry, the economy, or Global Predictions itself. Forward-looking statements are not guarantees of the underlying expected actions or future performance and future results may differ significantly from those anticipated by the forward-looking statements. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

¹ Data as of July 2024.

² Availability of tax loss harvesting depends on portfolio diversity.

³ As of August 6, 2024. The optional Cash Sweep program takes the cash sitting in your brokerage account and moves it to an FDIC-insured interest-earning deposit account. The current yield is 4.5%, rates subject to change at any time. The cash sweep program is made available in coordination with Apex Clearing Corporation. Please read the Important Disclosures for more information.

⁴ This analysis calculator tool is for illustrative purposes only and is not financial advice. We do not guarantee the accuracy of the results or their relevance to your particular circumstances. This calculator uses hypothetical historical data and does not take into account the effect of taxes on a taxable account. Hypothetical historical data is no guarantee of future performance and this calculator is not intended to predict actual performance. The input of different time periods, amounts, and fees will vary calculator results. Average ETF fee is based on the AUM weighted average of US ETFs as of September 2024, see more information. Note that you can purchase ETFs through Double, which may incur additional fees.

Full pricing details along with an FAQ can be found here

Data displayed in charts and graphics above are for illustrative purposes only and do not reflect actual investment results and are not a guarantee of future results.

By using double.finance, you accept our and . Double is only available to US residents.

See Double Finance Form ADV Part IIA for additional information. Double does not guarantee that the results of its advice, recommendations, or the objectives of its direct index or cash management strategies will be achieved. We make no assurance that the investment process will consistently lead to successful investing. Before you invest, you should carefully review and consider your investment objectives as well as the risks, charges, and expenses of the underlying securities. There is at least a $1,000 account minimum required to participate in Double's strategies, although some strategies may have higher minimums.

Double does not provide tax, or legal advice. Double's website, brokerage, and advisory services are not intended for persons of any jurisdiction where Double is not authorized to do business. Tax savings will vary from client to client due to many factors including market conditions, tax characteristics of securities, client-imposed investment restrictions, client tax rate or status, and changes in tax regulations.